No Data
World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Raises Target Price to $12
GeoVax Labs (GOVX) Receives a Buy From Noble Financial
Express News | GeoVax Labs Inc - Dsmb Recommends Continuation of Geo-Cm04S1 Vaccine Trial
Express News | GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of Covid-19 Vaccine Booster in Patients With Chronic Lymphocytic Leukemia
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients With Chronic Lymphocytic Leukemia
No Data
No Data
